Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Tina T Biss"'
Autor:
Jayanthi Alamelu, Tina T. Biss, Mary Mathias, Georgina W. Hall, Oliver Tunstall, Neha Bhatnagar, Elizabeth Chalmers, Charles R. M. Hay, Jeanette Payne, Daniel P. Hart, Ben Palmer, Michael Makris, Charles Percy, Kate Talks, Peter William Collins, Anne Riddell, Michael Richards, Ri Liesner, Jayashree Motwani
Publikováno v:
Haemophilia. 27:932-937
INTRODUCTION In good risk patients (historic inhibitor peak
Autor:
Maria Elisa Mancuso, Monika Maas Enriquez, Tina T. Biss, Despina Tseneklidou-Stoeter, MacGregor Steele, Maria Wang, Krista Fischer, Gili Kenet, Sanjay P Ahuja
Publikováno v:
Haemophilia
Introduction BAY 94‐9027 (damoctocog alfa pegol; an extended half‐life PEGylated recombinant factor VIII [FVIII]) demonstrated efficacy and safety in previously treated paediatric patients (PTPs) aged
Autor:
Elizabeth Chalmers, Tina T. Biss
Publikováno v:
British Journal of Haematology. 194:996-998
Autor:
Susan Baird, Fanny Bajolle, Sebastian Grunt, Olga Lvova, Anthonie W. A. Lensing, Mayte Sánchez van Kammen, William T. Smith, Paolo Simioni, Madhurima Majumder, Christoph Male, Jeanette Payne, Tina T. Biss, Michelle Morales Soto, Veerle Labarque, Elizabeth Chalmers, Joseph Palumbo, Jonathan M. Coutinho, Damien Bonnet, Amparo Santamaría, Riten Kumar, An Van Damme, Ida Martinelli, Kamar Godder, Sanjay J. Shah, Paul Monagle, Paola Saracco, Dagmar Kubitza, Philip Connor, Martin H. Prins, Rukhmi Bhat, Krisztián Kállay, Akos F. Pap, Scott D. Berkowitz, Kerry Hege, Jayashree Motwani, Helene L. Hooimeijer
Publikováno v:
Blood advances, 4(24), 6250-6258. The American Society of Hematology
Blood Advances
r-FISABIO. Repositorio Institucional de Producción Científica
instname
Blood advances, 4(24), 6250-6258. American Society of Hematology
Blood Adv.
Blood Adv
Blood Advances
r-FISABIO. Repositorio Institucional de Producción Científica
instname
Blood advances, 4(24), 6250-6258. American Society of Hematology
Blood Adv.
Blood Adv
Anticoagulant treatment of pediatric cerebral venous thrombosis has not been evaluated in randomized trials. We evaluated the safety and efficacy of rivaroxaban and standard anticoagulants in the predefined subgroup of children with cerebral venous t
Autor:
Julia Anderson, Sean Platton, Peter J. Baker, Keith Gomez, Ian Jennings, Tina T. Biss, Gillian C. Lowe
Publikováno v:
British journal of haematologyReferences. 195(1)
Autor:
Christoph Male, Anthonie W A Lensing, Joseph S Palumbo, Riten Kumar, Ildar Nurmeev, Kerry Hege, Damien Bonnet, Philip Connor, Hélène L Hooimeijer, Marcela Torres, Anthony K C Chan, Gili Kenet, Susanne Holzhauer, Amparo Santamaría, Pascal Amedro, Elizabeth Chalmers, Paolo Simioni, Rukhmi V Bhat, Donald L Yee, Olga Lvova, Jan Beyer-Westendorf, Tina T Biss, Ida Martinelli, Paola Saracco, Marjolein Peters, Krisztián Kállay, Cynthia A Gauger, M Patricia Massicotte, Guy Young, Akos F Pap, Madhurima Majumder, William T Smith, Jürgen F Heubach, Scott D Berkowitz, Kirstin Thelen, Dagmar Kubitza, Mark Crowther, Martin H Prins, Paul Monagle, Angelo C. Molinari, Ulrike Nowak Göttl, Juan Chain, Jeremy Robertson, Katharina Thom, Werner Streif, Rudolf Schwarz, Klaus Schmitt, Gernot Grangl, An Van Damme, Philip Maes, Veerle Labarque, Antonio Petrilli, Sandra Loggeto, Estela Azeka, Leonardo Brandao, Doan Le, Christine Sabapathy, Paola Giordano, Runhui Wu, Jie Ding, Wenyan Huang, Jianhua Mao, Päivi Lähteenmäki, Stephane Decramer, Toralf Bernig, Martin Chada, Godfrey Chan, Krisztian Kally, Beatrice Nolan, Shoshana Revel-Vilk, Hannah Tamary, Carina Levin, Daniela Tormene, Maria Abbattista, Andrea Artoni, Takanari Ikeyama, Ryo Inuzuka, Satoshi Yasukochi, Michelle Morales Soto, Karina A Solis Labastida, Monique H Suijker, Marike Bartels, Rienk Y Tamminga, C Heleen Van Ommen, D. Maroeska Te Loo, Rui Anjos, Lyudmila Zubarovskaya, Natalia Popova, Elena Samochatova, Margarita Belogurova, Pavel Svirin, Tatiana Shutova, Vladimir Lebedev, Olga Barbarash, Pei L Koh, Joyce C Mei, Ludmila Podracka, Ruben Berrueco, Maria F Fernandez, Tony Frisk, Sebastian Grunt, Johannes Rischewski, Manuela Albisetti-Pedroni, Ali Antmen, Huseyin Tokgoz, Zeynep Karakas, Jayashree Motwani, Michael Williams, John Grainger, Jeanette Payne, Mike Richards, Susan Baird, Neha Bhatnagar, Angela Aramburo, Shelley Crary, Tung Wynn, Shannon Carpenter, Sanjay Ahuja, Neil Goldenberg, Gary Woods, Kamar Godder, Ajovi Scott-Emuakpor, Gavin Roach, Leslie Raffini, Nirmish Shah, Sanjay Shah, Courtney Thornburg, Ayesha Zia, Roger Berkow
Publikováno v:
Lancet Haematology, 7, e18-e27
Lancet Haematol.
The Lancet Haematology
Lancet Haematology, 7(1), E18-E27. ELSEVIER SCI LTD
The Lancet Haematology, Elsevier, 2019, ⟨10.1016/S2352-3026(19)30219-4⟩
Lancet. Haematology, 7(1), e18-e27. Lancet Publishing Group
LANCET HAEMATOL, Vol. 7, no.1, p. 18-27 (2020)
Lancet Haematology, 7, 1, pp. e18-e27
The Lancet Haematology, 7(1), E18-E27. ELSEVIER SCI LTD
The Lancet Haematology, Elsevier, 2019, 7 (1), ⟨10.1016/S2352-3026(19)30219-4⟩
Lancet Haematology
r-FISABIO. Repositorio Institucional de Producción Científica
instname
Lancet Haematol.
The Lancet Haematology
Lancet Haematology, 7(1), E18-E27. ELSEVIER SCI LTD
The Lancet Haematology, Elsevier, 2019, ⟨10.1016/S2352-3026(19)30219-4⟩
Lancet. Haematology, 7(1), e18-e27. Lancet Publishing Group
LANCET HAEMATOL, Vol. 7, no.1, p. 18-27 (2020)
Lancet Haematology, 7, 1, pp. e18-e27
The Lancet Haematology, 7(1), E18-E27. ELSEVIER SCI LTD
The Lancet Haematology, Elsevier, 2019, 7 (1), ⟨10.1016/S2352-3026(19)30219-4⟩
Lancet Haematology
r-FISABIO. Repositorio Institucional de Producción Científica
instname
Contains fulltext : 219893.pdf (Publisher’s version ) (Closed access) BACKGROUND: Treatment of venous thromboembolism in children is based on data obtained in adults with little direct documentation of its efficacy and safety in children. The aim o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7274a4d6f1a8f89f43796a94d2a57da8
Autor:
Monika Maas Enriquez, MacGregor Steele, Maria Wang, Krista Fischer, Tina T. Biss, Gili Kenet, MariaElisa Mancuso, Sanjay P Ahuja
Publikováno v:
Blood. 136:40-41
Introduction BAY 94-9027 (damoctocog alfa pegol) is an extended-half-life PEGylated recombinant factor VIII approved for use in patients with hemophilia A aged ≥12 years (USPI; https://www.fda.gov/). Due to age-related pharmacokinetic and other dif
Autor:
Oliver Chapman, William Lester, Debra Ellis, K. Douglas, John-Paul Westwood, Sylvia Benjamin, Tanya Cranfield, Chiara Vendramin, Katy Langley, Tina T. Biss, J. J. van Veen, Karen Vanhoorelbeke, Lynn Manson, Ferras Alwan, Mari Thomas, Nichola Cooper, Quentin A. Hill, Steve Austin, Tina Dutt, Richard Gooding, Amanda Clark, Marie Scully, Vickie McDonald, Henry G. Watson, William Thomas, Keith Sibson
Publikováno v:
Blood. 130:466-471
Immune-mediated thrombotic thrombocytopenic purpura (TTP) is a life-threatening disorder caused by antibodies against ADAMTS13. From the United Kingdom TTP registry, we undertook a prospective study investigating the impact of the presenting anti-ADA
Autor:
Michael J R Desborough, Gillian C. Lowe, Tina T. Biss, Cheng Hock Toh, Daniel P. Hart, Phillip L R Nicolson
Publikováno v:
Clinical Medicine. 19:532-533
There is an associated link between clinical research engagement and improved patient outcomes.[1][1] Not only does this apply to the subjects of research but also to those patients who are not active participants but are treated at sites where resea
Autor:
Kunihiko Itoh, Tina T. Biss, Mia Wadelius, Fanny Bajolle, Kaitlyn Shaw, Anna-Karin Hamberg, Masanobu Takeuchi, Takuya Wakamiya, Masakatsu Yanagimachi, Masato Taguchi, Marie-Anne Loriot, Keita Hirai, Leonardo R. Brandão, Bruce Carleton, Richard H. Ho, Susan I. Vear, Shinya Ito, Farhad Kamali, Tohru Kobayashi, Keiichi Hirono
Publikováno v:
The pharmacogenomics journal. 20(2)
Studies on the effect of cytochrome P450 2C9 (CYP2C9), vitamin K epoxide reductase complex subunit 1 (VKORC1), and cytochrome P450 4F2 (CYP4F2) polymorphisms on warfarin maintenance dose in children are conflicting. We conducted a systematic review a